2Kaminski PF, Maier RC. Clear cell adenomcarcinoma of the cervix unrelated to diethylstilbestrol exposure [ J ]. Obstet Gynecol, 1983, 62(6) : 720-727.
3Hanselaar A, Loosbroek MV, Schuurbiers O, et al. Clear cell adenocarcinoma of ervix and vagina. An update of the Central Netherlands Registry showing twin age incidence peaks [ J ]. Cancer,1997, 79 ( 11 ) :2229-2236.
4Thomas MB, Wright JD, Leiser AL, et al. Clear cell carcinoma of the cervix :a multi-institutional review in the post-DES era [ J ]. Gynecol Oncol, 2008,109 ( 3 ) : 335-339.
5Melnick S, Cole P, Anderson D, et al. Rates and risks of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix: an update[J]. N Engl J Med,1987 ,316 :514-516.
6Reich O, Tamussino K, Lahousen M, et al. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stageIB-IIB disease in women not exposed in utero to diethylstilbestrol[ J]. Gynecol Oncol,2000,76:331-335.
7Boyd J, Takahashi H, Waggoner SE, et al. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethyl stilbestrol exposure in utero[J]. Cancer, 1996,77: 507-513.
8Pirog EC, Kleter B, Semra O, et al. Prevalence of human papillomavirus DNA indifferent histological subtypes of cervical adenocarcinoma[ J ]. Am J Pathol,2000,157 : 1055-1062.
9Goto K, Takeuchi Y, Yakihara A, et al. Synchronous invasive squamous cell carcinoma and clear cell adenocarcinoma of the uterine cervix: a different human papillomavirus status [ J ]. Gynecol Oncol,2005,97 ( 3 ) : 976-979.
3Reich O, Tamussino K, Lahousen M, et al. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage ⅠB- ⅡB disease in women not exposed in utero to diethylstilbestrol. Gynecol Oncol, 2000, 76:331-335.
4Hanselaar A, van Loosbroek M, Schuurbiers O, et al. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks. Cancer, 1997, 79:2229-2236.
5Waggoner SE, Anderson SM, Luce MC, et al. p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol, 1996, 60:339-344.
6Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer ( IBSCC ) Study Group. J Natl Cancer Inst, 1995, 87:796-802.
7Pirog EC, Kleter B, Olgac S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol, 2000, 157:1055-1062.
8Goto K, Takeuchi Y, Yakihara A, et al. Synchronous invasive squamous cell carcinoma and clear cell adenocarcinoma of the uterine cervix: a different human papillomavirus status. Gynecol Oncol, 2005, 97:976-979.
9Kaminski PF, Maier RC. Clear cell adenocarcinoma of the cervix unrelated to diethylstilbestrol exposure. Obstet Gynecol, 1983, 62:720-727.
10Bender DP, Sorosky JI, Buller RE, et al. Serum CA 125 is an independent prognostic factor in cervical adenocarcinoma. Am J Obstet Gynecol, 2003, 189:113-117.
